Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001209191-22-031842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-25 | 2022-05-23 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.50 | -10.6K | 266.2K | -4% | -$121.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-05-23 | S | D | 3,130 | $11.50 | 273,698 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-05-23 | S | D | 7,453 | $11.50 | 266,245 | D | — | — |